Document Report Card

Basic Information

ID: ALA1177665

Journal: Bioorg Med Chem

Title: Discovery of potent and orally active tricyclic-based FBPase inhibitors.

Authors: Tsukada T, Kanno O, Yamane T, Tanaka J, Yoshida T, Okuno A, Shiiki T, Takahashi M, Nishi T.

Abstract: With the aim of exploring the effect of tricyclic-based FBPase inhibitors in cells and in vivo, a series of prodrugs of tricyclic phosphonates was designed and synthesized. Introducing prodrug moieties into tricyclic-based phosphonates led to the discovery of prodrug 15c, which strongly inhibited glucose production in monkey hepatocytes. Furthermore, prodrug 15c lowered blood glucose levels in fasted cynomolgus monkeys.

CiteXplore: 20542703

DOI: 10.1016/j.bmc.2010.05.041